🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts stated the popularity for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Removal

According to TikTok, the platform has removed problematic content and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Digital Trading Activities

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with images of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Product Details and Costs

Inside these groups, posts show black plastic packages with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to potentially significant health risks”.